Amyloid b (Ab) is a critical factor involved in the pathogenesis of Alzheimer's disease (AD). We have previously demonstrated that continuous intracerebroventricular infusion of Ab1-40 induced a time-dependent expression of the inducible nitric oxide (NO) synthase (iNOS) and an overproduction of NO in the rat hippocampus. The pathophysiological significance of the overproduction of NO on brain function was manifested by an impairment of nicotine-evoked acetylcholine(ACh) release and memory deficits. 4 Molecular mechanisms by which NO participates in the Ab-induced brain dysfunction, however, remain to be determined. Here we show that chronic Ab1-40 infusion caused a robust peroxynitrite formation and subsequent tyrosine nitration of proteins in the hippocampus. Immunoprecipitation and Western blot analyses further revealed that synaptophysin, a synaptic protein, was a main target of tyrosine nitration. Chronic infusion of Ab1-40 resulted in an impairment of nicotine-evoked ACh release as analyzed by microdialysis. Daily treatment with the iNOS inhibitor aminoguanidine (AG) or the peroxynitrite scavenger uric acid (UA) prevented the tyrosine nitration of synaptophysin as well as the impairment of nicotine-evoked ACh release induced by Ab. Our findings suggest that the tyrosine nitration of synaptophysin is related to Ab-induced impairment of ACh release.
Accumulating evidence shows that oxidative reactions occur in AD and that Ab may be one molecular link between oxidative stress and AD-associated brain dysfunction. [1] [2] [3] [4] [5] [6] [7] It has been demonstrated that aggregation of Ab can attract inflammatory mediators 8, 9 which, in turn, generate NO radicals. 10 We have previously demonstrated that continuous intracerebroventricular infusion of Ab induced a time-dependent expression of iNOS in the hippocampus and that treatment with specific inhibitors for iNOS ameliorated Ab-induced impairment of nicotine-evoked ACh release and spatial memory deficits. 4 However, molecular mechanisms by which NO participates in the Ab-induced brain dysfunction remain to be determined.
An overproduction of NO induced by Ab1-40 may increase the formation of peroxynitrite. 11 Since peroxynitrite formation is a marker of oxidative stress, which has been found in AD brain tissues, 12 we utilized immunohistochemical staining with specific antibody, anti-nitrotyrosine, to detect whether or not infusion of Ab1-40 increases peroxynitrite formation. As shown in Figure 1 , there were numerous nitrotyrosine-positive cells in the hippocampus of Ab1-40-infused rats on day 5 after the start of the infusion (Figures 1b and c) , whereas much fewer cells were stained in the control group (Figure 1a ). This finding suggests that the infusion of Ab increases oxidative stress in vivo, which may contribute to brain dysfunction and neurodegeneration later on.
Next, we investigated whether Ab-induced peroxynitrite formation may result in a subsequent nitration of the tyrosine residues of proteins. Of those proteins of interest, the synaptic proteins are the most compelling since they play critical roles in the release of neurotransmitters 13 and in synaptic plasticity, which are thought to underlie learning and memory. 14, 15 Since Western blot analysis alone was not able to detect tyrosine-nitrated protein bands, we utilized immunoprecipitation with polyclonal anti-nitrotyrosine antibody and blot with monoclonal anti-nitrotyrosine antibody to determine whether or not proteins in the crude synaptosomal preparations are tyrosine-nitrated. We found only one tyrosine nitrated protein band at approximately 38 kDa (Figure 2a , upper image) under our experimental conditions. The signal of the tyrosine-nitrated protein band was strongest in Ab1-40-infused rats (Figure 2a , upper image, lane 2) while that of control rats was very faint (Figure 2a , upper image, lane 1). Daily treatment of iNOS inhibitor AG (100 mg/kg, i.p.), which has been shown to inhibit NO production in Ab1-40-infused rats, 4 or the specific peroxynitrite scavenger UA (200 mg/kg, i.p.), 16 prevented the tyrosine nitration of the target protein as manifested by reduced signals (Figure 2a , upper image, lanes 3 and 4, respectively). Quantification based on the optical density of those signals demonstrated that the tyrosine-nitrated protein level was significantly increased in Ab1-40-infused rats as compared with control, AG-treated and UA-treated rats (Figure 2b) . To identify what protein was tyrosine-nitrated, in the second blot we utilized anti-synaptophysin antibody because synaptophysin has a molecular weight of 38 kDa and it is tyrosine-nitrated by peroxynitrite in vitro. 17 As expected, we obtained a correlative band at 38 kDa (Figure 2a , lower image).
To further determine the extent of the tyrosine nitration of synaptophysin, we first immunoprecipitated total synaptophysin and blotted with anti-synaptophysin antibody and then with anti-nitrotyrosine antibody. The first blot with anti-synaptophysin antibody showed signals of synaptophysin band at 38 kDa (Figure 2c , upper band), which was not different among groups (Figure 2d ) indicating that the total amount of synaptophysin was not altered in control and Ab1-40-infused rats. Since synaptophysin is a marker of synaptic vesicles, 18 the results implied that synaptic loss had not occurred during this time course. The second blot with anti-nitrotyrosine antibody revealed differences in the extent of the tyrosine-nitrated synaptophysin among groups (Figure 2c , lower band), which was significantly different in the relative values of the tyrosine-nitrated Since the binding of synaptobrevin to synaptophysin is an important step to control the exocytotic process, 19 and tyrosine phosphorylation of synaptic proteins regulates their activities, 20 we examined whether tyrosine nitration of synaptophysin altered the incorporation to synaptobrevin as well as tyrosine phosphorylation. The synaptobrevin-synaptophysin complex can be immunoprecipitated by using either anti-synaptophysin or anti-synaptobrevin antibody and separated by sodium dodecyl sulfate-polycrylamide gel electrophoresis (SDS-PAGE). 19 As shown in Figure 3a , the signal of synaptobrevin bands was reduced in Ab1-40-infused rats (lane 2, lower band), which showed the increased tyrosine nitration of synaptophysin, as compared with control (lane 1, lower band) or UA-treated rats (lane 3, lower band). Since total synaptophysin levels were unaltered among three groups (upper band), it is possible that tyrosine nitration of synaptophysin may compromise the incorporation of synaptobrevin into synaptophysin-synaptobrevin complex. In another set of experiment, the total synaptophysin was immunoprecipitated and blotted with anti-phosphotyrosine antibody to examine the tyrosine phosphorylation state of synaptophysin in Ab1-40-infused rats. Interestingly, the signal of tyrosine-phosphorylated synaptophysin at the basal state was increased in Ab1- Continuous infusion of Ab1-40 for 10 days significantly impaired the nicotine-evoked ACh release as compared with Ab40-1-infused control rats (Figure 3b ). To investigate whether tyrosine nitration of synaptophysin is associated with this Ab-induced impairment of ACh release, rats were daily injected with the peroxynitrite scavenger UA (200 mg/kg, i.p.). The treatment significantly ameliorated the impairment of nicotine-evoked ACh release (Figure 3b) , and prevented the tyrosine nitration of synaptophysin (Figure 3a) .
We have previously demonstrated that chronic infusion of Ab1-40-induced iNOS mRNA expression and overproduction of NO in the hippocampus. 4 In the present study, we further demonstrated a downstream event of the biochemical processes from NO to the formation of peroxynitrite and the subsequent tyrosine nitration of the synaptic protein, synaptophysin, which we identified as only one tyrosinenitrated protein induced by Ab1-40 infusion. The physiological significance of the latest step is related to the impairment of cholinergic neurotransmission, which may underlie the memory deficits found in Ab-treated rats. 4, 6, 7, 21 We consider that not only synaptophysin but also other proteins may be tyrosinenitrated by Ab1-40 infusion, but we could not detect them by the immunoprecipitation/Western blot analysis, because their levels may be too low to be detected. Di Stasi et al 17 have also demonstrated that synaptophysin is a major substrate for tyrosine nitration induced by peroxynitrite in vitro. Synaptophysin is a major integral membrane protein of synaptic vesicles, which is required for vesicle fusion and release of neurotransmitters. 22, 23 It also plays an essential role in synaptic plasticity, which is thought to underlie learning and memory. 14, 15 The cytoplasmic carboxyl terminus of synaptophysin contains 10 copies of a tyrosine-rich pentapeptide repeat, 24 suggesting that this protein may be a target for the nitration of tyrosine residues and thereby altering its function involved in synaptic processes. It has been suggested that the formation of synaptophysinsynaptobrevin complex provides a rapidly available pool of vesicular synaptobrevin for exocytotic membrane fusion. 25 We found that the level of synaptobrevin coimmunoprecipitated with synaptophysin was decreased in Ab1-40-infused rats, but recovered in UA-treated rats, suggesting that less synaptobrevin is incorporated into the complex or the ability of synaptophysin to recruit synaptobrevin into the complex is reduced, and the nitration of tyrosine residues on synaptophysin affects the complex formation. While the domains of synaptobrevin and synaptophysin responsible for the interaction between the two proteins are cytoplasmic, 19 and the cytoplasmic domain of synaptophysin contains numerous tyrosine residues, 24 it is still unclear how this phenomenon takes place.
The tyrosine nitration of synaptophysin was expected to be a poor substrate for phosphotyrosine kinase; however, we found that the basal level of tyrosine phosphorylation of synaptophysin was increased in Ab1-40-infused rats. Further studies are Previously, we have reported that continuous infusion of neurotoxic Ab fragments, including Ab1-42, Ab1-40 and Ab25-35, impaired the cholinergic neurotransmission, 4, 6, 7, 21, 27 although there was no significant difference in the basal extracellular ACh and choline levels. Furthermore, the total level of synaptophysin, a marker of synaptic vesicles, 18 was not altered among groups, indicating that the impairment of the nicotine-evoked ACh release was not because of the reduction in the number of synaptic vesicles. Accordingly, the decrease of the nicotineevoked ACh release in Ab1-40-infused rats may be attributable to an impairment of cholinergic neurotransmission via nicotinic ACh receptors. Since presynaptic nicotinic ACh receptors are involved in modulation of release of ACh and other neurotransmitters, the impairment of the nicotine-evoked ACh release implies a dysfunction in synaptic processes of neurotransmitter release at an early stage caused by Ab in AD. This suggestion is supported by our previous findings that K þ -stimulated dopamine release in the striatum was also impaired in Ab-140-infused rats. 27 Thus, some selectivities of cholinergic impairment in AD may be a result of the secondary effects of Ab deposition in the brain areas that are innervated by the cholinergic system. Alternatively, a direct interaction between Ab and nicotinic ACh receptors may contribute to the selectivity of cholinergic impairment in AD. 29 
Methods

Animals and drug treatments
Male Wistar rats weighing 200-250 g at the beginning of the experiments were used. The procedure for infusion of Ab has been described previously. 28 Ab1-40 (Bachem AG, Bubendorf, Switzerland) was continuously infused into the lateral ventricle at a rate of 300 pmol/12 ml/day for 5 or 10 days. The peptide was dissolved in 35% acetonitrile/ 0.1% trifluoroacetic acid, being in a nonaggregated form within the pump. Control animals were infused with the nontoxic reverse fragment Ab40-1. Accumulation of Ab in the hippocampus was demonstrated immunohistochemially with anti-Ab (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) antibodies, but no Congo red birefringence was observed.
21 AG (100 mg/kg, i.p.) (Sigma, St Louis, MO, USA), an iNOS inhibitor, or UA (200 mg/kg, i.p.) (Wako Chemicals, Osaka, Japan), a peroxynitrite scavenger, was administered daily for 5 days (Western blot analysis for tyrosine-nitrated synaptophysin) or 10 days (in vivo microdialysis) after the start of Ab infusion.
Immunohistochemical staining for peroxynitrite On day 5 after Ab infusion, rats were anesthetized with pentobarbital and intracardially perfused with physiological saline, followed by 4% paraformaldehyde in 100 mM phosphate buffer saline (PBS, pH 7.4). The brains were quickly removed, postfixed for 24 h in the same fixative solution and cryoprotected in a 40% sucrose solution in 100 mM PBS. Sections were cut 30 mm thick in a cryostat and collected in 100 mM PBS containing 0.05% Tween-20. Free-floating sections were incubated with rabbit polyclonal anti-nitrotyrosine antibody (diluted 1:200) (Upstate Biotechnology, Lake Placid, NY, USA) for 24 h at 41C. The sections were then incubated with appropriate serum-conjugated avidin-biotinylated enzyme complex (ABC kit, Vector Laboratories, Burlingame, CA, USA) anti-rabbit IgG antibodies for 1 h at room temperature and stained by diaminobenzidine. Preparation of crude synaptosomes and immunoprecipitation of nitrated proteins and synaptophysin Crude synaptosomes (P2) were prepared from hippocampal tissue using the method described elsewhere. . The band intensities of the film were analyzed by densitometry. To calculate the relative value of nitrated synaptophysin, membranes used for total synaptophysin were stripped with stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl, pH 6.7) at 501C for 10 min, incubated with anti-nitrotyrosine antibody, and detected as described above. The relative values of nitrated synaptophysin were calculated as a ratio of the band intensity in the second blot (nitrated synaptophysin) to the first blot (total synaptophysin).
Microdialysis and determination of ACh release
Ten days after the start of the Ab infusion, the cannula delivering Ab was removed and a dialysis probe for the measurement of ACh release was implanted. 4, 27 Rats were anesthetized with pentobarbital and fixed in a stereotaxic frame. A dialysis probe (A-I-8-03; membrane length 3 mm, EICOM, Kyoto, Japan) was implanted into a region extending from the frontoparietal cortex to hippocampus (AP-3.8; L 2.2; V 1.0-4.0 mm), since deposition of Ab was observed in the frontal cortex and hippocampus around the ventricle. 21 About 24 h after the implantation of the dialysis probe, Ringer's solution (147 mM NaCl, 4 mM KCl, and 2.3 mM CaCl 2 ) containing 10 À5 M eserin was perfused at a flow rate of 2.0 ml/min and dialysate was collected every 15 min and analyzed by HPLC with electrochemical detection (ECD). Details of the measurement of ACh by HPLC-ECD have been described previously. 30 
Statistical analyses
The results are expressed as mean7SEM Statistical significance in the neurochemical experiments was determined by two-way ANOVA, followed by the two-tailed Bonferroni test for multigroup comparison, or the Wilcoxon test or Student's t-test for two-group comparison. A P-value less than 0.05 was regarded as statistically significant.
